Ge Long Hui A P P

Search documents
牧原股份(002714.SZ):8月商品猪销售收入118.5亿元
Ge Long Hui A P P· 2025-09-05 09:30
Core Viewpoint - Muyuan Foods (002714.SZ) reported a significant increase in the sales volume of live pigs for August 2025, but experienced a decline in sales price and revenue compared to the previous year [1] Sales Performance - The company sold 7.001 million live pigs in August 2025, representing a year-on-year increase of 27.10% [1] - Sales to its wholly-owned subsidiary, Muyuan Meat Products Co., Ltd. and its subsidiaries accounted for 2.591 million live pigs [1] Pricing and Revenue - The average selling price of live pigs was 13.51 yuan per kilogram, showing a year-on-year decrease of 31.46% [1] - Total sales revenue from live pigs reached 11.85 billion yuan, reflecting a year-on-year decline of 12.30% [1]
华银电力(600744.SH):湖南能源拟减持不超过1%股份
Ge Long Hui A P P· 2025-09-05 09:29
Core Viewpoint - Hunan Energy plans to reduce its stake in Huayin Power (600744.SH) through centralized bidding, with a maximum of 20,311,242 shares, representing up to 1% of the company's total share capital [1] Group 1 - Hunan Energy intends to sell shares over a period of 90 consecutive days [1] - The total number of shares to be sold does not exceed 1% of the company's total share capital [1]
华兴源创(688001.SH):累计回购0.32%股份 回购计划已实施完毕
Ge Long Hui A P P· 2025-09-05 09:28
格隆汇9月5日丨华兴源创(688001.SH)公布,截至本公告披露日,公司本次回购计划已实施完毕。公司 以集中竞价交易方式累计回购公司股份1,439,317股,占公司总股本的比例为0.32%,回购成交的最高价 为34.78元/股,最低价为22.66元/股,支付的资金总额为人民币40,288,431.55元(不含印花税、交易佣金 等交易费用)。 ...
牧原股份:8月商品猪销售收入118.5亿元,同比减少12.30%
Ge Long Hui A P P· 2025-09-05 09:24
格隆汇9月5日|牧原股份(002714.SZ)公告称,2025年8月,公司销售商品猪700.1万头,同比增加 27.10%,商品猪销售均价13.51元/公斤,同比减少31.46%,商品猪销售收入118.5亿元,同比减少 12.30%。 ...
海天瑞声(688787.SH)拟使用不超8亿元的暂时闲置自有资金进行现金管理
Ge Long Hui A P P· 2025-09-05 09:24
格隆汇9月5日丨海天瑞声(688787.SH)公布,公司本次拟使用不超过人民币80,000万元(含本数)的暂时 闲置自有资金进行现金管理,使用期限自本公司董事会审议通过之日起12个月内有效。在前述额度及决 议有效期限内,资金可以循环滚动使用。 ...
龙虎榜丨天华新能20%涨停,深股通净买入1.9亿元
Ge Long Hui A P P· 2025-09-05 09:19
Group 1 - Tianhua New Energy (300390.SZ) experienced a 20% limit-up today, with a turnover rate of 15.67% and a transaction volume of 2.349 billion yuan [1] - The net buying from the Shenzhen Stock Connect amounted to 190 million yuan, with total net buying from various trading seats reaching 283 million yuan [1] - The top five buying trading seats included the Shenzhen Stock Connect, which contributed 2.447579 billion yuan, accounting for 10.42% of the total transaction volume [1] Group 2 - The largest buying trading seat was the Shenzhen Stock Connect, with 46.89% of the total transactions, followed by institutional trading seats [2] - The total buying amount from the top five buying and selling trading seats combined was 4.564185 billion yuan, representing 19.43% of the total transaction volume [2]
真爱美家(003041.SZ):2025年半年度利润分配10派4元 股权登记日9月12日
Ge Long Hui A P P· 2025-09-05 09:19
格隆汇9月5日丨真爱美家(003041.SZ)公布,公司2025年半年度利润分配方案为:以公司现有总股本 144,000,000股为基数,向全体股东每10股派4元人民币现金(含税)。本次利润分配股权登记日2025年9月 12日。除权除息日2025年9月15日。 ...
灿瑞科技(688061.SH):董事长提议公司回购2000万元-4000万元股份
Ge Long Hui A P P· 2025-09-05 09:16
格隆汇9月5日丨灿瑞科技(688061.SH)公布,收到公司实际控制人、董事长罗立权先生《关于提议上海 灿瑞科技股份有限公司回购公司股份的函》。罗立权先生提议公司以自有资金和回购专项贷款通过上海 证券交易所交易系统以集中竞价交易方式回购公司股份,拟回购股份资金总额:不低于人民币2000万 元,不超过人民币4000万元。 ...
ST葫芦娃(605199.SH):获得头孢地尼胶囊药品注册证书
Ge Long Hui A P P· 2025-09-05 09:16
Core Viewpoint - ST HuLuWa (605199.SH) has received the drug registration certificate for Cefdinir capsules from the National Medical Products Administration, indicating a significant regulatory approval for the company’s product line [1] Group 1: Product Information - Cefdinir is a third-generation broad-spectrum cephalosporin antibiotic [1] - The drug is indicated for infections caused by various bacteria, including Staphylococcus, Streptococcus, and Escherichia coli, among others [1] - Specific infections treated by Cefdinir include pharyngitis, tonsillitis, acute bronchitis, pneumonia, otitis media, sinusitis, pyelonephritis, cystitis, and several skin and soft tissue infections [1]
步长制药(603858.SH)拟注销控股子公司步长医学诊断
Ge Long Hui A P P· 2025-09-05 09:14
格隆汇9月5日丨步长制药(603858.SH)公布,公司于2025年9月4日召开第五届董事会第三十一次会议, 审议通过了《关于拟注销步长(广州)医学诊断技术有限公司暨关联交易的议案》,为优化公司资源配 置,降低管理成本,公司拟注销步长(广州)医学诊断技术有限公司(称"步长医学诊断")。 ...